Looking to buy Retatrutide in the UK? Nova Biolabs holds Retatrutide 10mg and 30mg in UK domestic stock, HPLC-verified at >98% purity, with same or next-day dispatch in discreet packaging.
Retatrutide is a synthetic peptide that simultaneously engages three receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor. This triple-receptor mechanism — adding glucagon receptor agonism to the GLP-1/GIP dual action of Tirzepatide — gives Retatrutide a pharmacological profile unlike any previously studied incretin analogue.
The addition of glucagon receptor activation is of particular research interest due to glucagon's role in hepatic glucose output, energy expenditure signalling, and adipose tissue metabolism — pathways not directly engaged by dual-agonist compounds.
Retatrutide provides a unique research model for studying the simultaneous co-activation of three receptor pathways. Researchers can isolate each receptor's contribution using selective antagonists, enabling detailed dissection of the signalling hierarchy.
The glucagon receptor component of Retatrutide is of particular value in hepatic cell models studying gluconeogenesis, glycogenolysis, and hepatic glucose output — pathways central to metabolic disease research.
Glucagon receptor activation has well-documented effects on thermogenesis and energy expenditure signalling. Retatrutide enables researchers to study these pathways within the context of simultaneous incretin receptor engagement.
Retatrutide is widely used alongside Tirzepatide and Semaglutide in comparative studies designed to quantify the additional research value of each successive receptor addition — from GLP-1 only, to GLP-1/GIP, to the full triple agonist profile.
Nova Biolabs stocks Retatrutide in 10mg (£35) and 30mg (£65) vials — the 30mg offering the best value per milligram for extended research programmes.
Store lyophilised Retatrutide at 2–8°C, away from light. Stable up to 24 months. Reconstitute with bacteriostatic water and use the peptide dosing calculator for exact measurements. Use reconstituted material within 28 days.
The key pharmacological difference is the glucagon receptor:
For researchers studying hepatic metabolism, energy expenditure signalling, or requiring the broadest possible incretin receptor coverage, Retatrutide provides the more comprehensive research tool.
All Nova Biolabs peptides are research grade, HPLC-verified and held in UK stock for same or next-day dispatch.
Browse All Products →Nova Biolabs now carries two pre-filled retatrutide pens for researchers who prefer a ready-to-use format. The Re:Age Retatrutide 40mg Pen (£130) offers a compact 40mg option from Re:Age, while the Alluvi Retatrutide 100mg Pen (£160) provides 4 × 10mg doses with no reconstitution required from Alluvi Healthcare. Both are held in UK domestic stock alongside the standard lyophilised vials. View all retatrutide formats →